Björn Fahlén

Björn Fahlén has a diverse work experience in the finance industry, including positions at PÄAB and Redeye AB. Starting in May 2016, they worked as a Partner at PÄAB. Prior to that, Björn held various roles at Redeye AB, starting with Equity Research Analyst, Life Sciences in November 2003. Björn later became the Corporate Broker, Life Sciences in January 2009 and eventually rose to the position of CEO in February 2012.

Björn Fahlén started their education journey in 1989 at Älmhult, where they pursued a degree of unknown nature. Björn then went on to attend Växjö University from 1994 to 1996, obtaining an Engineer's Degree in Chemical Engineering. Continuing their educational pursuits, Björn joined KTH Royal Institute of Technology in 1997 and completed a Master's Degree in Analytical Chemistry in 1998. Björn later went on to Stockholm University, where they obtained a Master's Degree in Biochemistry from 1996 to 2000. Björn further advanced their studies at Stockholm University from 2000 to 2002 and earned a Bachelor's Degree in Economics. Lastly, from 2000 to 2003, Björn Fahlén completed their education at Stockholm University with a Licentiate of Philosophy (Ph.L.) degree in the field of Biochemistry.